+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-02-06Number of Pages: 78

Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Global Organ Preservation Solutions Market: Snapshot

The global market for organ preservation solutions is expected to witness substantial growth throughout the forecast period. The rising number of opportunities through strategic partnership with research organizations and medical institutions is projected to help the prominent players in expanding their consumer base. In addition, the growing focus on advanced in the medical sector is likely to contribute widely towards the development of the overall market in the next few years. However, the limited medical reimbursements for organ transplantation and donation are estimated to curb the growth of the overall market in the next few years.

According to the study, in 2012, the global market for organ preservation solutions was worth US$0.06 bn and is estimated to reach a value of US$0.20 bn by the end of 2019. Thanks to the rising awareness among consumers regarding the benefits of donation of organs, the global market is predicted to register a progressive 16.50% CAGR between 2013 and 2019.

Growing Awareness Concerning Organ Donation to Accelerate Growth

The rising NGO and government initiatives to encourage organ donation and the increasing number of solid-organ transplantation procedures are some of the vital factors expected to fuel the growth of the global organ preservation solutions market in the near future. Additionally, the tremendously rising cases of organ failures worldwide and technological developments in this field are predicted to supplement the growth of the market. However, the high cost of organ transplantation is estimated to restrict the growth of the market in the near future.

On the basis of solution, the global organ preservation solutions market has been divided into viaspan, RENOGRAF, hypoThermosol, custodiol HTK, PERFADEX, lifor human bioSystems, and siRNA Transplant Solutions. Furthermore, the key segments of the global organ preservation solutions market in terms of preservation are static cold storage, hypothermic perfusion preservation, and others. Innovations in the preservation methods is expected to offer promising opportunities for the leading market players.

Rising Number of Organ Donors to Supplement Growth of Europe Organ Preservation Solutions Market

From a geographical perspective, the global organ preservation solutions market can be divided into Europe, Asia Pacific, North America, and the Rest of the World. In 2012, Europe led the global market and is expected to remain in the leading position in the next few years. Thanks to the technological advancements in this field, the Europe market for organ preservation solutions is projected to register a progressive growth rate in the near future. In addition, the substantial contribution from Spain is expected to accelerate the growth of the market in the near future.

Furthermore, the rising number of organ donors and the policy of being an organ donor after death are some of the factors estimated to contribute towards the growth of the Europe market. The increasing awareness regarding the need for organ donation among the people and the rising number of initiatives taken by government to encourage organ donation are some of the other factors projected to fuel the growth of the market in the near future.

Some of the leading players operating in the organ preservation solutions market across the globe are Teva Pharmaceutical Industries Ltd., Claris Lifesciences Limited, BioTime, Inc., XVIVO Perfusion AB, Dr. Franz Köhler Chemie GmbH, Lifeline Scientific, CryoLife, Inc., ToleroTech, Inc., Bristol-Myers Squibb, BioLife Solutions, Inc., and 21st Century Medicine. The rising number of players in the market are projected to strengthen the competitive scenario of the global organ preservation solutions market in the next few years.

 

Organ preservation solutions are used to preserve organs before transplantation procedure as these organs in external climate are vulnerable and also become dysfunctional once taken out from the human body. To preserve and maintain organs functionality for their further usage such as transplantation and research, organ preservation solutions are used. Increasing demand for organ transplantation procedures across the globe is expected to drive the growth of organ preservation solutions market. In addition, aging population will also propel the growth of organ preservation solutions market as the risk of organ failure in elderly people increases that augments the demand for organ transplants. Likewise, development of technologically advanced solutions for preserving organs will further accentuate the growth of organ preservation solutions market.

 

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved. These solutions include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). The market for these solutions has been extensively analyzed based on number of organ transplant, efficiency and application area. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

Based on the type of preservation techniques used to preserve organs, market has been segmented as hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques). The market for these technologies has been extensively analyzed based on number of organ transplant, compatibility with solution and organs, and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for this segment. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global ultrasound devices market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.

 

The global organ preservation solutions market has been segmented as below:

 

Organ Preservation Solutions Market, by Solution 

  • Viaspan
  • Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
  • RENOGRA
  • HypoThermosol
  • PERFADEX
  • Lifor
  • Human BioSystems (HBS) Solution
  • siRNA Transplant Solutions
  • Others

Organ Preservation Solutions Market, by Preservation Technique

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others 

Organ Preservation Solutions Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)


 
 
Back To Top